A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
Some recent data suggest that, for now, COVID-19 may be a year-round problem, driven more by human behavior and immunity levels than weather patterns. Credit: Unsplash / Maxime The pandemic may no ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of ...
Shifting guidelines bred confusion and put the onus on individuals for deciding when to mask, test and stay home. 2022 was the year many people decided the coronavirus pandemic had ended. President ...
Millions of people who once qualified for free COVID vaccination are now excluded. They must either pay out-of-pocket for a private vaccine or go without. The price of a private COVID jab in the UK is ...
GMA Network on MSN
DOH: Scare over flu-like sickness likely linked to COVID-19 PTSD
The fear and anxiety experienced by some Filipinos amid recent reports on Influenza-like Illnesses (ILI) are likely ...
LONDON — The World Health Organization is estimating that nearly 15 million people were killed either by the coronavirus or by its impact on overwhelmed health systems in the past two years, more than ...
Recent weeks have seen successive rises in reported COVID infection numbers across Australia, with figures in some states indicating virus levels not seen since early 2023. The growing wave of COVID, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback